H-FTISADTSK-OH

Ref. 3D-PP40620

Produktinformation

• Name: H-FTISADTSK-OH
• Synonyme: NH2-Phe-Thr-Ile-Ser-Ala-Asp-Thr-Ser-Lys-OH

Beschreibung

Peptide H-FTISADTSK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FTISADTSK-OH include the following: Streamlined workflow for absolute quantitation of therapeutic monoclonal antibodies using Promise Proteomics mAbXmise kits and a TSQ Altis Plus mass YE Song, D Lebert, JV Guillaubez, S Samra , E Goucher - promise-proteomics.comhttps://promise-proteomics.com/wp-content/uploads/2023/06/tn-001753-cl-clinical-altis-mabs-tn001753-na-en.pdf Conjugation site characterization of antibody-drug conjugates using electron-transfer/higher-energy collision dissociation (EThcD) Y Song, J Gao, Q Meng, F Tang, Y Wang, Y Zeng - Analytica Chimica , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000326702300199X Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab S Schokker , F Fusetti, F Bonardi, RJ Molenaar - MAbs, 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/19420862.2020.1795492 LC-MS/MS validation analysis of trastuzumab using dSIL approach for evaluating pharmacokinetics RH Budhraja , MA Shah, M Suthar, A Yadav , SP Shah - Molecules, 2016 - mdpi.comhttps://www.mdpi.com/1420-3049/21/11/1464 LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma P Bults , R Bischoff , H Bakker, JA Gietema - Analytical , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.5b04276 Analytical and pharmacological consequences of the in vivo deamidation of trastuzumab and pertuzumab P Bults , A van der Voort, C Meijer, GS Sonke - Analytical and , 2022 - Springerhttps://link.springer.com/article/10.1007/s00216-021-03756-z Enrichment and Liquid Chromatography-Mass Spectrometry Analysis of Trastuzumab and Pertuzumab Using Affimer Reagents O Olaleye, B Spanov, R Ford, N Govorukhina - Analytical , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.1c02807 and Takashi Shimada N Iwamoto, N Yamane, Y Umino, A Hamadac - researchgate.nethttps://www.researchgate.net/profile/Akinobu-Hamada/publication/283003878_Development_of_the_validated_LCMS_bioanalysis_of_Trastuzumab_in_human_plasma_using_selective_detection_method_for_complementarity-determining_regions_of_monoclonal_antibody_nano-surface_and_molecular-/links/56582f5008aefe619b207dac/Development-of-the-validated-LCMS-bioanalysis-of-Trastuzumab-in-human-plasma-using-selective-detection-method-for-complementarity-determining-regions-of-monoclonal-antibody-nano-surface-and-molecular.pdf The development of the validated LCMS bioanalysis of trastuzumab in human plasma using a selective detection method for complementarity-determining regions of N Iwamoto, N Yamane, Y Umino, A Hamada - Analytical , 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/ay/c5ay01588j Hybrid ligand binding immunoaffinity-liquid chromatography/mass spectrometry for biotherapeutics and biomarker quantitation: how to develop a hybrid LBA M Yuan, OA Ismaiel , WRJ Mylott - Rev , 2019 - betasciencepress-publishing.comhttps://betasciencepress-publishing.com/10-17145/fulltext/rss/hybrid-ligand-binding-immunoaffinity-liquid-chromatography-mass-spectrometry-for-biotherapeutics-and-biomarker-quantitation-how-to-develop-a-hybrid-lba-lc-ms-ms-method-for-a-protein/ Use of an alternative signature peptide during development of a LC-MS/MS assay of plasma nivolumab levels applicable for multiple species M Ohuchi, S Yagishita , K Taguchi, Y Goto - of Chromatography B, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570023220313659 Antibody Drug Conjugate Bioanalysis using the BioBA Solution M Deng, I Moore - sciex.jphttps://sciex.jp/content/dam/SCIEX/pdf/tech-notes/all/ADC-Bioanalysis-BioBA-solution.pdf Optimizing hybrid LC-MS/MS binding conditions is critical: impact of biotransformation on quantification of trastuzumab L Liu, K Xu, J Li, M Maia , M Mathieu, R Elliott , J Yang - Bioanalysis, 2018 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/bio-2018-0196 Simultaneous quantification of co-administered trastuzumab and pertuzumab in serum based on nano-surface and molecular-orientation limited (nSMOL) proteolysis L Liu, B Sun, J Cai, J Wang, W Liu, H Hu, S Chen - RSC advances, 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/ra/d4ra03060e Method development and validation of LC-MS/MS-based assay for the simultaneous quantitation of trastuzumab and pertuzumab in cynomolgus monkey serum and L Gui, L Li, L Dong, S Xiang, J Zhai - Biomedical , 2020 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/bmc.4903 Augmented clearance of nivolumab is associated with renal functions in chronic renal disease model rats K Taguchi, Y Hayashi, M Ohuchi, H Yamada - Drug Metabolism and , 2022 - ASPEThttps://dmd.aspetjournals.org/content/50/6/822.abstract Investigation of native and aggregated therapeutic proteins in human plasma with asymmetrical flow field-flow fractionation and mass spectrometry I Ramm , M Leeman , H Schagerlöf, IR Leon - Analytical and , 2022 - Springerhttps://link.springer.com/article/10.1007/s00216-022-04355-2 Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion HH Chiu , YJ Tsai, C Lo, CH Lin, IL Tsai, CH Kuo - Analytica Chimica Acta, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267021011454 Quantification of the Antibody Drug Conjugate, Trastuzumab Emtansine, and the Monocolonal Antibody, Trastuzumab, in Plasma Using a Generic Kit-Based H Yang, ME Lame, S Naughton, EE Chambers - waters.comhttps://www.waters.com/content/dam/waters/en/app-notes/2016/720005619/720005619-en.pdf Transition of average drug-to-antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography H Habara, H Okamoto, Y Nagai, M Oitate - & Drug Disposition, 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bdd.2371 Improving Quantification of Protein Therapeutics by Standardising the Sample Preparation Approach to LC-MS/MS Analysis: High-sensitivity Bioanalysis of EE Chambers, ME Lame - 2016 - researchgate.nethttps://www.researchgate.net/profile/Karen-Haas/publication/303483394_Improving_Quantification_of_Protein_Therapeutics_by_Standardising_the_Sample_Preparation_Approach_to_LC-MSMS_Analysis_High-sensitivity_Bioanalysis_of_Infliximab_and_Total_Antibody_Quantification_of_th/links/5744963c08ae9ace8421a432/Improving-Quantification-of-Protein-Therapeutics-by-Standardising-the-Sample-Preparation-Approach-to-LC-MS-MS-Analysis-High-sensitivity-Bioanalysis-of-Infliximab-and-Total-Antibody-Quantification-of.pdf UPLC-MS/MS Method for the Quantification of Trastuzumab in Human Serum at the 5-nM Level Using Xevo TQD MS and ACQUITY UPLC H-Class System CE Doneanu, RS Plumb - gimitec.comhttps://gimitec.com/file/720004423en.pdf TWO DIMENSIONAL LC-SRM ASSAY FOR TRASTUZUMAB IN HUMAN SERUM CE Doneanu, H Yang, P Rainville, S Berger, RS Plumb - waters.comhttps://www.waters.com/webassets/cms/library/docs/2013wcbp_doneanu_2dlc.pdf Single source solution for low flow chromatography C Hunter , L De Souza, C Seto, Y Kang, L Bedford - sciex.jphttps://www.sciex.jp/content/dam/SCIEX/pdf/tech-notes/all/Single-Source-Solution-for-Low-Flow-Chromatography.pdf Advantages of online two-dimensional chromatography for MRM quantification of therapeutic monoclonal antibodies in serum C Doneanu, P Rainville, RS Plumb - RADAR and PICS Compendium, 2012 - waters.comhttps://www.waters.com/content/dam/waters/en/app-notes/2012/720004510/720004510-ko.pdf Optimization of Trypsin Digestion for MRM Quantification of Therapeutic Proteins in Serum C Doneanu, H Yang, PD Rainville, E Bouvier - Waters , 2012 - waters.comhttps://www.waters.com/content/dam/waters/en/app-notes/2012/720004507/720004507-de.pdf Aptamer-based sample purification for mass spectrometric quantification of trastuzumab in human serum B Sun, J Liu, P Cai, J Wu, W Liu, H Hu, L Liu - Talanta, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0039914023001005

• Marke: Biosynth